Android app on Google Play

BMO Capital Downgrades Bristol-Myers Squibb Co. (BMY) to Market Perform

November 12, 2012 7:19 AM EST Send to a Friend
Get Alerts BMY Hot Sheet
Price: $49.99 -0.1%

Rating Summary:
    10 Buy, 6 Hold, 4 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 10 | Down: 9 | New: 11
Trade BMY Now!
Join SI Premium – FREE
BMO Capital downgraded Bristol-Myers Squibb Co. (NYSE: BMY) from Outperform to Market Perform with a price target of $37.00 (from $38.00).

For an analyst ratings summary and ratings history on Bristol-Myers Squibb Co. click here. For more ratings news on Bristol-Myers Squibb Co. click here.

Shares of Bristol-Myers Squibb Co. closed at $32.23 yesterday.




You May Also Be Interested In


Related Categories

Analyst PT Change, Downgrades

Related Entities

BMO Capital

Add Your Comment